Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 21, 2019
VirTrial has announced a training and certificate program to help clinical research professionals prepare for hybrid decentralized clinical trials (DCT) which include a combination of virtual and in-person visits. The program is free to all members ...
read more
Friday, November 04, 2022
QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, announced the launch of their new cell line database developed through its partnership with ATCC, a biological materials organization, developer and supplier of authenticated cell ...
read more
Monday, February 26, 2018
Catalyst Biosciences announced they have entered into a manufacturing agreement with AGC Biologics for the process transfer and commercial scale cGMP manufacturing of CB 2679d.
read more
Waverley Pharma announced its wholly-owned Irish Subsidiary has submitted a Marketing Authorization application through the European Union's De-Centralized Procedure for an anti-cancer generic drug.
read more
Sharp, part of UDG Healthcare plc has announced the appointment of Kevin Orfan as president of Sharp Packaging US.
read more
Thursday, December 27, 2012
PAREXEL International Corporation announced today that on December 21, 2012, the Company acquired all of the outstanding equity securities of Liquent, Inc., a leading global provider of Regulatory Information Management (RIM) solutions. Liquent ...
read more
The Truvada (emtricitabine/tenofovir disoproxil fumarate) tablet label was recently updated to expand the indication to include pediatric patients weighing at least 12 kilograms and the addition of the following strength tablets (100/150 mg, 133/200 ...
read more
Wednesday, December 01, 2021
Molecular Targeting Technologies, Inc. (MTTI) and Evergreen Theragnostics, Inc., announced an agreement in which Evergreen will manufacture MTTI's EvaThera™ platform of radiopharmaceuticals.
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Wednesday, November 04, 2020
The FDA is alerting clinical laboratory staff and health care providers that false positive results can occur with antigen tests, including when users do not follow the instructions for use of antigen tests for the rapid detection of SARS-CoV-2.
read more
Granules announced the U.S. FDA has approved its Abbreviated New Drug Applications for Methylergonovine 0.2 mg tablets.
read more
SGS Life Science Services has announced the completed construction of its Shanghai, China, cGMP chemistry and biotechnology testing laboratories.
read more
EMED announced the SCIg60 Infusion System has been granted expanded indications as the only Immune Globulin Subcutaneous mechanical pump infusion system cleared by the FDA.
read more
Thursday, September 26, 2024
Phesi has launched a self-service Investigator Site Profile solution designed to eliminate the non-active and non-enrolling investigator sites that development programs are typically burdened with. Investigator Site Profile leverages data from Phesi’...
read more
MedReleaf and BioPharma Services have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products.
read more